The Company owns total assets of 364 million Yuan with a registered capital of 100 million Yuan.
The Company's main production base is at 1317 Jianchuan Road, Minhang District, covering an area of 59,608 square meters, with a total floor area of 35,935 square meters.
The Company now has 960 employees.
The Company has the production workshops for liquid injection, powder injection and materials, in which run a number of production lines for sterile lyophilized injection, sterile liquid injection and sterilized liquid injection. It produces 150 million vials of liquid injection, 40 million vials of lyophilized powder injection and the associated API products annually.
At present the Company has 219 officially approved kinds of products. The production core technologies of biological extraction, purification, herbal extraction and API self-supply integration and the core productivity of freeze-dried preparation integration have taken shape. By the end of 2009, 25 products of the Company had been put in the "National Essential Drugs List".
The modern workshop for lyophilized powder injection was completed at the end of 2009. It was designed in compliance with EU standards and CGMP requirements. With the annual capacity of 70 million vials of injection, it will further upgrade the Company's core productivity of freeze-dried preparations.
The Company, under the leadership of Mr. Chen Binhua, the General Manager, adhering to the company spirit of "cherishing love in every injection produced for lifetime reliance", keeping abreast with the advanced pharmaceutical technologies in the world, continuously cultivates and uplifts its core competitiveness to stride forward in the area of modern medicine.